Division of Newborn Medicine.
Institutional Centers for Clinical and Translational Research, Boston Children's Hospital, Boston, MA, USA.
J Vet Diagn Invest. 2021 Sep;33(5):913-919. doi: 10.1177/10406387211027899. Epub 2021 Jul 5.
The immature platelet fraction (IPF) is a measure of newly released platelets, which has been used as a marker of platelet production in multiple human studies but is not widely available in multispecies analyzers. We developed gates to measure the IPF in diluted and undiluted murine blood samples on the Sysmex XN-1000V multispecies hematology analyzer. IPF gates were created using undiluted and diluted (1/10) blood samples obtained from adult and newborn (postnatal day 10, P10) C57BL/6J wild-type (WT) mice, and from 3 murine models of thrombocytopenia: mice, which lack the thrombopoietin receptor (hyporegenerative); antibody-mediated thrombocytopenia; and acute inflammation-induced thrombocytopenia. P10 mice were chosen because, at their size, we could consistently obtain (by terminal phlebotomy) the blood volume needed to run an undiluted sample. The undiluted blood IPF gate successfully differentiated between mechanisms of thrombocytopenia in both adult and P10 mice. For diluted samples, 2 IPF gates were generated: a thrombocytopenic (T) gate, which performed well in samples with platelet counts (PCs) <800 × 10/L in adult mice and <500 × 10/L in newborn mice, and a non-thrombocytopenic (NT) gate, which performed well in samples with PCs above these thresholds. PCs and IPFs measured in diluted blood using these gates agreed well with those measured in undiluted blood and had good reproducibility. These diluted gates allow for the accurate measurement of PCs and IPFs in small (10 µL) blood volumes, which can be obtained easily from adult and newborn mice as small as P1 to assess platelet production serially.
未成熟血小板分数(IPF)是一种新释放血小板的测量指标,已在多项人类研究中被用作血小板生成的标志物,但在多物种分析仪中尚未广泛应用。我们开发了门控来测量稀释和未稀释的鼠血样本中的 IPF,这些样本是在 Sysmex XN-1000V 多物种血液分析仪上获得的。使用来自成年和新生(出生后第 10 天,P10)C57BL/6J 野生型(WT)小鼠的未稀释和稀释(1/10)血液样本以及 3 种血小板减少症的鼠模型:缺乏血小板生成素受体的小鼠(再生不良);抗体介导的血小板减少症;以及急性炎症诱导的血小板减少症。选择 P10 小鼠是因为,在它们的大小下,我们可以始终获得(通过末端采血)运行未稀释样本所需的血量。未稀释血液的 IPF 门控成功地区分了成年和 P10 小鼠中血小板减少症的机制。对于稀释样本,生成了 2 个 IPF 门控:血小板减少症(T)门控,在成年小鼠血小板计数(PC)<800×10/L 和新生小鼠<500×10/L 的样本中表现良好,以及非血小板减少症(NT)门控,在 PC 高于这些阈值的样本中表现良好。使用这些门控在稀释血液中测量的 PC 和 IPF 与在未稀释血液中测量的结果吻合良好,且具有良好的重现性。这些稀释门控允许在小体积(10μL)血液中准确测量 PC 和 IPF,从小至 P1 的成年和新生小鼠中很容易获得这些血液,以连续评估血小板生成。